This is despite a recent transgenic mouse model of AD reporting that enhancement of the cGAMP-STING pathway leads to the upregulation of microglia TREM2, which in turn suppresses amyloid-β-related neuropathology [54]. Here, STING1 is linked to Alzheimer disease.